Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

In an exploratory unadjusted analysis, mean 25(OH)D decreased across ICDR categories from no DR to proliferative DR (23.4 to 15.2 ng/mL; P for trend < 0.001).

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Case-control study.

Case-control study

Compares people with an outcome against people without it, examining exposures.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Serum 25-hydroxyvitamin D levels and prevalent diabetic retinopathy in adults with type 2 diabetes: a retrospective hospital-based matched case-control study

Source: Article title.

Participants were eligible only when a 25(OH)D result was available within ±7 days of bilateral fundus photography.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Serum 25-hydroxyvitamin D levels and prevalent diabetic retinopathy in adults with type 2 diabetes: a retrospective hospital-based matched case-control study

Case-control study · Frontiers in Nutrition · 2026

Original publication title

Serum 25-hydroxyvitamin D levels and prevalent diabetic retinopathy in adults with type 2 diabetes: a retrospective hospital-based matched case-control study

Rong-Feng Dai; Yu Qian; Si-Qi Liu; Yu-Qing You; Yan Han; Yi Fang

Copyright © 2026 Dai, Qian, Liu, You, Han and Fang.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

In this selectively tested, single-center tertiary-hospital sample, lower serum 25(OH)D was concurrently associated with higher prevalence odds of DR. Given the retrospective cross-sectional case: control design, this finding should be interpreted as an association only; it does not establish temporality or causality, and selection bias, residual confounding, and reverse causality remain possible.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Diabetic retinopathy (DR) is a major microvascular complication of type 2 diabetes mellitus (T2DM). This study examined the adjusted association between serum 25-hydroxyvitamin D [25(OH)D] and prevalent DR.

Source: Background

Abstract: What methods does the paper describe?

This retrospective, single-center matched case: control study was conducted at a tertiary hospital in China among adults with T2DM treated between January 2023 and March 2025. Serum 25(OH)D testing was not routine for all patients and was ordered at the treating clinician’s discretion. Participants were eligible only when a 25(OH)D result was available within ±7 days of bilateral fundus photography. Cases had prevalent DR and controls had no DR; individual 1:2 matching used sex, age within ±3 years, and diabetes duration within ±2 years.

The prespecified primary analysis modeled 25(OH)D continuously in conditional logistic regression, and missing covariates were handled by multiple imputation.

Source: Methods

Abstract: Results

The final sample included 399 selectively tested participants (133 with DR and 266 without DR) in 133 matched sets. Mean serum 25(OH)D was 18.6 ± 7.4 ng/mL in the DR group and 23.4 ± 8.1 ng/mL in the non-DR group. In the prespecified adjusted model, each 10 ng/mL higher serum 25(OH)D level was associated with lower prevalence odds of DR (OR, 0.62; 95% CI, 0.48 to 0.81; p < 0.001). Additional adjustment for continuous age and diabetes duration yielded a similar estimate (OR, 0.63; 95% CI, 0.48 to 0.83; p = 0.001).

In an exploratory unadjusted analysis, mean 25(OH)D decreased across ICDR categories from no DR to proliferative DR (23.4 to 15.2 ng/mL; P for trend < 0.001).

Source: Results

Abstract: Conclusion

In this selectively tested, single-center tertiary-hospital sample, lower serum 25(OH)D was concurrently associated with higher prevalence odds of DR. Given the retrospective cross-sectional case: control design, this finding should be interpreted as an association only; it does not establish temporality or causality, and selection bias, residual confounding, and reverse causality remain possible.

Source: Conclusion
Authors’ abstract

Background

Diabetic retinopathy (DR) is a major microvascular complication of type 2 diabetes mellitus (T2DM). This study examined the adjusted association between serum 25-hydroxyvitamin D [25(OH)D] and prevalent DR.

Methods

This retrospective, single-center matched case: control study was conducted at a tertiary hospital in China among adults with T2DM treated between January 2023 and March 2025. Serum 25(OH)D testing was not routine for all patients and was ordered at the treating clinician’s discretion. Participants were eligible only when a 25(OH)D result was available within ±7 days of bilateral fundus photography. Cases had prevalent DR and controls had no DR; individual 1:2 matching used sex, age within ±3 years, and diabetes duration within ±2 years.

The prespecified primary analysis modeled 25(OH)D continuously in conditional logistic regression, and missing covariates were handled by multiple imputation.

Results

The final sample included 399 selectively tested participants (133 with DR and 266 without DR) in 133 matched sets. Mean serum 25(OH)D was 18.6 ± 7.4 ng/mL in the DR group and 23.4 ± 8.1 ng/mL in the non-DR group. In the prespecified adjusted model, each 10 ng/mL higher serum 25(OH)D level was associated with lower prevalence odds of DR (OR, 0.62; 95% CI, 0.48 to 0.81; p < 0.001). Additional adjustment for continuous age and diabetes duration yielded a similar estimate (OR, 0.63; 95% CI, 0.48 to 0.83; p = 0.001).

In an exploratory unadjusted analysis, mean 25(OH)D decreased across ICDR categories from no DR to proliferative DR (23.4 to 15.2 ng/mL; P for trend < 0.001).

Conclusion

In this selectively tested, single-center tertiary-hospital sample, lower serum 25(OH)D was concurrently associated with higher prevalence odds of DR. Given the retrospective cross-sectional case: control design, this finding should be interpreted as an association only; it does not establish temporality or causality, and selection bias, residual confounding, and reverse causality remain possible.

Publication and source details

Original title: Serum 25-hydroxyvitamin D levels and prevalent diabetic retinopathy in adults with type 2 diabetes: a retrospective hospital-based matched case-control study

Rong-Feng Dai; Yu Qian; Si-Qi Liu; Yu-Qing You; Yan Han; Yi Fang

Frontiers in Nutrition · 2026

* Correspondence: Rong-Feng Dai, RongfengDai0101@outlook.comCopyright © 2026 Dai, Qian, Liu, You, Han and Fang.2026Dai, Qian, Liu, You, Han and Fanghttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-07T19:42:27+00:00

DOI: 10.3389/fnut.2026.1828254 · PMC13682978